PSL Group Executive and Leadership Team

Michele Fearon, the Chief Executive Officer at PSL Group, directs the overarching corporate strategy and global vision for the organization. Fearon oversees the expansion of fieldwork services across North America, Europe, and Asia, ensuring alignment with the evolving needs of pharmaceutical market research agencies. By fostering high-level relationships with healthcare communication firms, the Chief Executive Officer drives long-term growth and market penetration. Michele Fearon maintains a focus on integrating clinical evidence with professional marketing messages to enhance physician engagement programs. This leadership role involves constant collaboration with the Board to refine the company's international footprint and service delivery models. Through rigorous oversight of organizational performance, Fearon ensures that the company remains a leader in the healthcare communication sector. Ultimately, Fearon secures the firm's competitive advantage by prioritizing innovation in data-driven market research and clinical education.

Neil Corner, the Chief Executive Officer, AI LaunchPad, PSL Group at PSL Group, architects the integration of artificial intelligence into the company's core service offerings. Corner leads the development of advanced technological tools designed to streamline pharmaceutical market research and enhance the precision of clinical evidence delivery. By overseeing the AI LaunchPad division, the Chief Executive Officer drives the adoption of machine learning to optimize physician engagement and educational program efficacy. Neil Corner collaborates with cross-functional teams to ensure that AI-driven insights translate into actionable strategies for global healthcare clients. This role involves identifying emerging technological trends and deploying scalable solutions that support the company's international operations. Through the strategic application of AI, Corner improves the speed and accuracy of fieldwork services. Ultimately, Corner positions the organization at the forefront of digital transformation within the pharmaceutical consulting landscape.

Tim Houghton, the Chief Executive Officer, MEC Domain at PSL Group, manages the specialized medical domain expertise that underpins the company's clinical education programs. Houghton directs the synthesis of professional marketing messages with complex clinical data to ensure resonance with physician audiences. By overseeing the MEC Domain, the Chief Executive Officer drives the quality and scientific integrity of all educational content delivered to healthcare professionals. Tim Houghton coordinates with internal research teams to translate clinical evidence into compelling communication strategies for global agencies. This leadership role involves maintaining high standards for medical accuracy while supporting the company's expansion into diverse international markets. Through the continuous refinement of domain-specific methodologies, Houghton enhances the value proposition for pharmaceutical clients. Ultimately, Houghton ensures that the organization delivers authoritative and impactful medical content that bridges the gap between clinical research and clinical practice.

Jim Karr, the Chief Financial Officer at PSL Group, directs the financial planning, reporting, and fiscal strategy for the entire organization. Karr oversees the management of capital resources and investment decisions that support the company's international growth and service expansion. By monitoring financial performance across all business units, the Chief Financial Officer drives profitability and ensures the long-term sustainability of the firm's operations. Jim Karr collaborates with the executive team to align budgetary priorities with the company's mission of delivering high-impact pharmaceutical market research. This role involves managing risk, overseeing financial compliance, and providing the data-driven insights necessary for strategic decision-making. Through the rigorous oversight of fiscal health, Karr supports the company's ability to invest in new technologies and market opportunities. Ultimately, Karr ensures the financial stability required to maintain the organization's leadership position in the global healthcare communication sector.

Elizabeth Barron, the Chief Operating Officer at PSL Group, executes the daily operational strategies that sustain the company's global fieldwork and consulting services. Barron oversees the internal processes and resource allocation required to deliver PV update programs and clinical education initiatives efficiently. By managing the operational workflow, the Chief Operating Officer drives productivity and ensures that service delivery meets the rigorous demands of international pharmaceutical clients. Elizabeth Barron coordinates with regional teams to streamline project execution and maintain consistent quality standards across all global offices. This leadership role involves optimizing organizational structures to support rapid scaling and market expansion. Through the implementation of performance metrics and operational best practices, Barron enhances the company's ability to execute complex projects on time and within budget. Ultimately, Barron secures the operational excellence necessary to maintain the firm's reputation in the healthcare communication industry.

Jill Myerow, the Group President, Business Unit, Peerscience at PSL Group, directs the strategic growth and service delivery of the Peerscience division. Myerow oversees the development of specialized programs that combine professional marketing with clinical evidence to engage physicians effectively. By leading this business unit, the Group President drives the creation of tailored solutions for pharmaceutical market research and healthcare communication agencies. Jill Myerow coordinates with cross-functional teams to ensure that the division's offerings remain relevant in a rapidly changing global market. This leadership role involves fostering client relationships and identifying new opportunities for service innovation within the medical communication space. Through the focused management of the Peerscience portfolio, Myerow enhances the company's ability to deliver high-value insights to its clients. Ultimately, Myerow secures the division's market impact by maintaining a commitment to scientific rigor and strategic communication excellence.

Kim Nachbaur, the Executive President, Enterprise Partnerships at PSL Group, architects the strategic alliances and large-scale client relationships that drive the company's global revenue. Nachbaur oversees the engagement with major pharmaceutical and healthcare communication agencies to secure long-term partnerships. By directing the enterprise sales strategy, the Executive President drives the expansion of the company's fieldwork services into new international territories. Kim Nachbaur collaborates with other senior leaders to ensure that partnership models align with the company's overall mission of delivering evidence-based physician engagement. This role involves negotiating complex agreements and managing the lifecycle of high-value client accounts. Through the cultivation of deep industry connections, Nachbaur enhances the company's market presence and competitive standing. Ultimately, Nachbaur secures the firm's growth by building sustainable, mutually beneficial relationships with key players in the global healthcare ecosystem.

Kristin Stockett, the Executive President, Enterprise Partnerships, Peerdirect at PSL Group, directs the strategic development and management of the Peerdirect enterprise partnership portfolio. Stockett oversees the expansion of direct-to-physician communication channels and fieldwork services for major healthcare clients. By leading the Peerdirect division, the Executive President drives the adoption of innovative engagement strategies that leverage clinical evidence to influence physician behavior. Kristin Stockett coordinates with internal teams to ensure that partnership initiatives are executed with precision and align with the company's broader market research goals. This leadership role involves identifying strategic opportunities for growth within the global pharmaceutical landscape and building strong, collaborative relationships with enterprise partners. Through the effective management of the Peerdirect unit, Stockett enhances the company's ability to deliver targeted and impactful communication programs. Ultimately, Stockett secures the division's success by driving consistent value for clients and stakeholders.

Stephanie Kennedy-Harris, the Group President at PSL Group, directs the operational and strategic initiatives for key business segments within the organization. Kennedy-Harris oversees the delivery of high-quality fieldwork services and clinical education programs to a diverse range of international healthcare communication agencies. By managing these business segments, the Group President drives the integration of professional marketing messages with clinical evidence to ensure maximum impact. Stephanie Kennedy-Harris collaborates with other C-suite leaders to refine service delivery models and expand the company's reach in North America and beyond. This role involves overseeing team performance, fostering client satisfaction, and ensuring that all programs meet the highest standards of scientific and professional excellence. Through the strategic management of these business units, Kennedy-Harris enhances the company's overall market position. Ultimately, Kennedy-Harris secures the firm's reputation by delivering consistent, high-value results for pharmaceutical clients.

Ahsan Haque, the Chief Technology Officer at PSL Group, architects the robust digital infrastructure required to support global pharmaceutical market research and fieldwork services. Haque oversees the development and maintenance of secure platforms that facilitate data collection and client communication across North America, Latin America, and beyond. By directing the technology roadmap, the Chief Technology Officer drives the implementation of scalable systems that handle complex clinical evidence and marketing data. Ahsan Haque collaborates with other C-suite leaders to ensure that technological capabilities align with the company's strategic goals for international growth. This role involves managing cybersecurity protocols and optimizing data processing workflows to maintain operational efficiency. Through the deployment of cutting-edge software solutions, Haque supports the delivery of high-quality services to healthcare communication agencies. Ultimately, Haque ensures the reliability and security of the company's digital ecosystem.